Mechanisms of primary immunodeficiencies: From bed-side to bench and back

Drug Discovery Today: Disease Mechanisms

Volumn 1, Issue 3, 2004, Pages 383-390

  Notarangelo, Luigi D ^a   Mazzolari, Evelina ^a   Forino, Concetta ^a   Giliani, Silvia ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; RECOMBINANT DNA;

B LYMPHOCYTE; CELL SURVIVAL; COMBINED IMMUNODEFICIENCY; ENZYME REPLACEMENT; GENE THERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE SYSTEM; MAJOR HISTOCOMPATIBILITY COMPLEX; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PHENOTYPE; PURINE METABOLISM; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 23744457609     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2004.10.008     Document Type: Review

References (42)

1. Fischer, A. (2001) Primary immunodeficiency diseases: an experimental model for molecular medicine. Lancet 357, 1863-1869
2. Noguchi, M. et al. (1993) Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73, 147-157
3. O'Shea, J.J. et al. (2004) A new modality for immunosuppression: targeting the JAK/STAT pathway. Nat. Rev. Drug Discov. 3, 555-564
4. Roifman, C.M. (2000) Interleukin-2 receptor alpha deficiency. Pediatr. Res. 48, 6-11
5. Willerford, D.M. et al. (1995) Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3, 521-530
6. + severe combined immunodeficiency. Nat. Genet. 20, 394-397
7. Giliani, S., et al. Interleukin-7 receptor a (IL-7Ra) deficiency: cellular and molecular bases. Analysis of clinical, immunological, and molecular features in 16 novel patients. Immunol. Rev. (in press)
8. Von Freeden-Jerry, U. et al. (1995) Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181, 1519-1526
9. Peschon, J.J. et al. (1994) Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180, 1955-1960
10. Lodolce, J.P. et al. (1998) IL-15 receptor maintains lymphocyte homeostasis by supporting lymphocyte homing and proliferation. Immunity 9, 669-676
11. Macchi, P. et al. (1995) Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 377, 65-68
12. Russell, S.M. et al. (1995) Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 270, 797-800
13. Notarangelo, L.D. et al. (2001) Recombinase activating gene enzymes of lymphocytes. Curr. Opin. Hematol. 8, 41-46
14. Schwarz, K. et al. (1996) RAG mutations in human B cell-negative SCID. Science 274, 97-99
15. Moshous, D. et al. (2001) Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 105, 177-186
16. Villa, A. et al. (1998) Partial V(D)J recombination activity leads to Omenn syndrome. Cell 93, 885-896
17. Moshous, D. et al. (2003) Partial T and B lymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis. J. Clin. Invest. 111, 381-387
18. Dadi, H.K. et al. (2003) Effect of CD38 deficiency on maturation of α/β and γ/δ T-cell lineages in severe combined immunodeficiency. N. Engl. J. Med. 349, 1821-1828
19. Arnaiz-Villena, A. et al. (1992) Primary immunodeficiency caused by mutations in the gene enconding the CD3-γ subunit of the T-lymphocyte receptor. N. Engl. J. Med 327, 529-533
20. Soudais, C. et al. (1993) Independent mutations of the human CD3-epsilon gene resulting in a T cell receptor/CD3 complex immunodeficiency. Nat. Genet. 3, 77-81
21. Kung, C. et al. (2000) Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease. Nat. Med. 6, 343-345
22. Tchilian, E.Z. et al. (2001) A deletion in the gene encoding the CD45 antigen in a patient with SCID. J. Immunol. 166, 1308-1313
23. Masternak, K. et al. (1998) A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients. Nat. Genet. 20, 273-277
24. Villard, J. et al. (1997) Mutation of RFXAP, a regulator of MHC class II genes, in primary MHC class II deficiency. N. Engl. J. Med. 337, 748-753
25. Steimle, V. et al. (1995) A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev. 9, 1021-1031
26. Steimle, V. et al. (1993) Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or Bare Lymphocyte Syndrome). Cell 75, 135-146
27. Gadola, S.D. et al. (2000) TAP deficiency syndrome. Clin. Exp. Immunol. 121, 173-178
28. Arpaia, E. et al. (1994) Defective T cell receptor signaling and CD8+ thymic selection in humans lacking Zap-70 kinase. Cell 76, 947-958
29. Hershfield, M. (2004) Combined immune deficiencies due to purine enzyme defects. In Immunologic Disorders in Infants and Children (Stiehm, E.R., Ochs, H.D., Winkelstein, J.A. eds), pp. 480-504, Elsevier Saunders
30. Ozsahin, H. et al. (1997) Adenosine deaminase deficiency in adults. Blood 89, 2849-2855
31. Santisteban, I. et al. (1993) Novel splicing, missense, and deletion mutations in 7 adenosine deaminase-deficient patients with late/delayed onset of combined immunodeficiency disease. Contribution of genotype to phenotype. J. Clin. Invest. 92, 2291-2302
32. Glanzmann, E. and Riniker, P. (1950) Essentielle lymphocytophthyse. Ein neues Krankheitsbild aus der Sauglings-pathologie. Ann. Paediatr. (Basel) 175, 1-32
33. Good, R.A. (1954) Agammaglobulinemia - a provocative experiment of nature. Bull. Univ. Minn. Med. Found. 26, 1-19
34. Fischer, A. (2003) Have we seen the last variant of severe combined immunodeficiency? N. Engl. J. Med. 349, 1789-1792
35. Gatti, R.A. et al. (1968) Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 2, 1366-1369
36. Antoine, C. et al. (2003) Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet 361, 553-560
37. Myers, L.A. et al. (2002) Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival. Blood 99, 872-878
38. Wengler, G.S. et al. (1996) In-utero transplantation of parental CD34 haematopoietic progenitor cells in a patient with X-linked severe combined immunodeficiency (SCIDXI). Lancet 348, 1484-1487
39. Flake, A.W. et al. (1996) Treatment of X-linked severe combined immunodeficiency by in transplantation of paternal bone marrow. N. Engl. J. Med. 335, 1806-1810
40. Hacein-Bey-Habina, S. et al. (2002) Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N. Engl. J. Med. 346, 1185-1193
41. Aiuti, A. et al. (2002) Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296, 2410-2413
42. Hacein-Bey-Habina, S. et al. (2003) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302, 415-419